Adicet bio to host conference call to provide updates on its clinical pipeline and corporate outlook

Redwood city, calif. & boston--(business wire)--adicet bio, inc. (nasdaq: acet), a clinical stage biotechnology company discovering and developing allogeneic gamma delta t cell therapies for cancer, today announced that the company will host a conference call and webcast presentation on thursday, january 4, 2024 at 8:00am et to provide an update on its clinical pipeline and corporate outlook. conference call and webcast event the live webcast of the presentation can be accessed by registering u.
ACET Ratings Summary
ACET Quant Ranking